2025-12-23 - Analysis Report
Okay, let's break down the provided information for Linde PLC (LIN).

**0) Overview:**

*   Ticker: LIN
*   Company Name: Linde PLC
*   Overview: A global industrial gases and engineering company.

**1) Return Rate Comparison (LIN vs. VOO):**

*   LIN Cumulative Return: 60.38%
*   VOO (S&P 500) Cumulative Return: 100.88%
*   Divergence: -40.5 (LIN underperformed VOO)
*   Relative Divergence: 11.5 (This indicates that the current divergence is near the lower end of its historical range.)

**Analysis:** Linde has significantly underperformed the S&P 500. The relative divergence suggests this underperformance is near its worst compared to historical fluctuations.

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD    | Alpha | Beta  | Cap(B) |
|------------|--------|--------|-------|-------|--------|
| 2015-2017  | 36.0%  | 9.2%   | 8.0%  | 0.0   | 72.9   |
| 2016-2018  | 27.0%  | 69.9%  | 12.0% | 0.2   | 73.5   |
| 2017-2019  | 41.0%  | 69.9%  | 19.0% | 0.4   | 100.3  |
| 2018-2020  | 14.0%  | 78.6%  | -10.0% | 0.4   | 124.2  |
| 2019-2021  | 63.0%  | 78.6%  | 16.0% | 0.9   | 163.2  |
| 2020-2022  | 37.0%  | 78.6%  | 38.0% | 0.8   | 153.7  |
| 2021-2023  | 43.0%  | 76.7%  | 41.0% | 0.5   | 193.5  |
| 2022-2024  | 6.0%   | 76.7%  | -14.0% | 0.5   | 197.3  |
| 2023-2025  | -13.0% | 79.5%  | -79.0% | 0.5   | 198.6  |

**Analysis:**

*   **CAGR:** The Compound Annual Growth Rate fluctuates significantly, showing strong growth in some periods and decline in others.
*   **MDD:** The Maximum Drawdown is high across the board, indicating substantial volatility.
*   **Alpha:** Alpha is inconsistent, ranging from positive (outperformance relative to the market) to deeply negative (significant underperformance). The recent years show a very negative Alpha.
*   **Beta:** Beta values are generally low (around 0.2-0.9), suggesting LIN is less volatile than the overall market.
*   **Cap(B):** Market capitalization has generally increased over time, although it experienced a drop between 2020-2022.

**2) Recent Stock Price Fluctuations:**

*   Close: 421.43
*   Last-market: {'price': 423.51, 'previousClose': 421.43, 'change': 0.49}
*   5-day SMA: 420.65
*   20-day SMA: 408.33
*   60-day SMA: 430.80

**Analysis:** The stock price is currently trading above its 5-day and 20-day SMAs, but below its 60-day SMA. This suggests a short-term upward trend but potential resistance at the 60-day level. The slight positive change in the last market indicates a minor upward movement.

**3) RSI, PPO and Expected Return:**

*   MRI: 0.8 (Medium Investment)
*   RSI: 59.00
*   PPO: 0.9068
*   Hybrid Signal: Buy 100% of cash (2 shares - Safe (OverSold Boost) - MRI:0.80) Dividend_1.50 (Cash Ratio: 0% on 2025-12-03)
*   Recent (20 days) relative divergence change: 1.7 (+) (Short-term increase)
*   Expected Return (%): 233.6

**Analysis:**

*   The Medium Investment rating and the Buy signal suggests positive outlook.
*   The RSI is near 60, indicating slightly bullish sentiment but not yet overbought.
*   The PPO being positive suggests that the short-term moving average is above the long-term moving average, indicating an upward trend.
*   The positive change in divergence indicates a short-term upward trend.
*   The Expected Return is very high, suggesting significant potential long-term gains, but this should be viewed with caution and considered alongside other factors.

**4) Recent News & Significant Events:**

*   **Cramer's Critique and Credit Facility:** Indicates scrutiny and potential financial activity.
*   **S.E.E.D. Planning Group LLC Raises Stock Holdings:** Positive signal, suggesting institutional confidence.
*   **Analyst Forecasts and Key Catalysts:** Hints at upcoming factors influencing the stock.
*   **UBS Reaffirms Buy on Linde (LIN) at $500:** Positive analyst outlook, with a significant price target.
*   **Linde Stock 6-Day Winning Spree:** Shows recent positive momentum.
*   **Reassessing Linde (LIN) Valuation:** Suggests market awareness of the stock's performance and attempts to justify its value.

**Analysis:** Recent news paints a mixed picture. There are positive signs like institutional buying, a recent winning streak, and a reaffirmed "Buy" rating from UBS with a high price target. However, there's also mention of scrutiny, reassessment of valuation, and a critique from Cramer, indicating potential concerns.

**4-2) Analyst Opinions:**

*   Consensus: Strong Buy (1.50)
*   Target Price (avg/high/low): 502.71 / 565.00 / 381.00
*   Recent Rating Changes: No changes listed.

**Analysis:** The analyst consensus is strongly positive, with a "Strong Buy" rating and an average target price significantly above the current price. This suggests analysts, on average, believe the stock is undervalued. The lack of recent rating changes suggests the positive sentiment has been consistent.

**5) Recent Earnings Analysis:**

| 날짜       | EPS  | 매출      |
|------------|------|-----------|
| 2025-10-31 | 4.11 | 8.62 B$   |
| 2025-08-01 | 3.75 | 8.49 B$   |
| 2025-05-01 | 3.53 | 8.11 B$   |
| 2024-10-31 | 3.24 | 8.36 B$   |
| 2025-10-31 | 3.24 | 8.36 B$   |

**Analysis:**

*   **EPS:** EPS has generally been increasing, showing profitability growth.
*   **Revenue:** Revenue has also shown an overall upward trend. The most recent quarter shows the highest revenue.
*   The duplicate 2025-10-31 / 3.24 / 8.36 B$ probably belongs to 2024-01-31.

**6) Financial Information:**

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-09-30   | $8.62B    | 49.17%        |
| 2025-06-30   | $8.49B    | 49.31%        |
| 2025-03-31   | $8.11B    | 48.75%        |
| 2024-12-31   | $8.28B    | 47.84%        |
| 2024-09-30   | $8.36B    | 47.87%        |

**Analysis:** Revenue has generally increased over the past five quarters, as well as Profit Margin.

**Capital and Profitability:**

| Quarter      | Equity    | ROE    |
|--------------|-----------|--------|
| 2025-09-30   | $38.62B   | 5.00%  |
| 2025-06-30   | $38.52B   | 4.59%  |
| 2025-03-31   | $38.03B   | 4.40%  |
| 2024-12-31   | $38.09B   | 4.53%  |
| 2024-09-30   | $39.17B   | 3.96%  |

**Analysis:** Equity has been relatively stable. ROE (Return on Equity) has shown an overall upward trend, indicating improved profitability relative to shareholders' equity.

**7) Comprehensive Analysis (Summary):**

*   **Underperformance:** Linde has underperformed the S&P 500 significantly, but the short-term divergence is improving.
*   **Volatility:** High MDD indicate volatile returns.
*   **Mixed Sentiment:** Recent news and analyst opinions are mixed, with positive buy ratings and target prices contrasted by media scrutiny and valuation concerns.
*   **Improving Financials:** Revenue, profit margins, EPS, and ROE are generally trending upward, suggesting improving financial health.
*   **Positive Indicators:** The current technical indicators (RSI, PPO, Hybrid signal) suggest a buy. The MRI suggesting medium investment.
*   **Very High Expected Return:** The very high expected return should be considered cautiously. The analysts targets are more aligned with reality.

**Overall Recommendation:**

Based on the provided data, Linde presents a complex picture. While the stock has underperformed the S&P 500, recent financial performance has been improving. Analyst sentiment is largely positive, and technical indicators suggest a short-term buy signal. However, it's crucial to consider the recent media scrutiny and high MDD. While the 233.6% expected return is eye-catching, it's important to take it with a grain of salt.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.